Hypothesis: Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity
- PMID: 29958888
- DOI: 10.1016/j.cca.2018.06.029
Hypothesis: Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity
Abstract
We have long thought that remnant lipoproteins (RLP) in plasma are significantly increased as the result of disturbed lipoprotein metabolism followed by obesity and insulin resistance. Therefore, it was believed that insulin resistance causes and enhances RLP formation. In contrast, this hypothesis states that RLP induces insulin resistance as the result of obesity associated with the excessive fat intake. The majority of plasma TG increased after fat intake is TG in RLP (RLP-TG) and the majority of postprandial RLP is VLDL remnants, not CM remnants. RLP is newly formed lipoproteins primarily for energy supply against starvation, like blood sugar after carbohydrate intake. Since RLP bearing apoE, LPL and Lp(a) function as ligands for the VLDL receptor, RLP interacts with the VLDL receptor in visceral fat adipocytes and stored as TG similar to excessive blood sugar. However, the excessive VLDL remnants induces obesity and its associated insulin resistance, which plays a major role as the initiator of metabolic domino effects, similar to blood sugar primarily serving as an energy supply to protect against starvation.
Keywords: Cholesteryl ester transfer proteins (CETP). VLDL receptor; Chylomicron (CM) (remnants); Fat load; Insulin resistance; Lipoprotein lipase (LPL); Postprandial lipoproteins; Remnant lipoproteins (RLP); VLDL (remnants).
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.Clin Chim Acta. 2018 Mar;478:200-215. doi: 10.1016/j.cca.2017.12.039. Epub 2018 Jan 4. Clin Chim Acta. 2018. PMID: 29307667 Review.
-
The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.Clin Chim Acta. 2019 Aug;495:382-393. doi: 10.1016/j.cca.2019.05.004. Epub 2019 May 10. Clin Chim Acta. 2019. PMID: 31078566
-
Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.Curr Opin Endocrinol Diabetes Obes. 2018 Apr;25(2):108-117. doi: 10.1097/MED.0000000000000393. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 29493553 Review.
-
The characteristics of remnant lipoproteins in the fasting and postprandial plasma.Clin Chim Acta. 2012 Jul 11;413(13-14):1077-86. doi: 10.1016/j.cca.2012.02.026. Epub 2012 Mar 13. Clin Chim Acta. 2012. PMID: 22433787
-
Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestine.Clin Chim Acta. 2019 Mar;490:12-16. doi: 10.1016/j.cca.2018.12.010. Epub 2018 Dec 14. Clin Chim Acta. 2019. PMID: 30553860
Cited by
-
Obesity and Dyslipidemia: A Review of Current Evidence.Curr Obes Rep. 2023 Sep;12(3):207-222. doi: 10.1007/s13679-023-00518-z. Epub 2023 Jul 6. Curr Obes Rep. 2023. PMID: 37410248 Review.
-
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype.Lipids Health Dis. 2020 May 9;19(1):90. doi: 10.1186/s12944-020-01273-z. Lipids Health Dis. 2020. PMID: 32386512 Free PMC article. Clinical Trial.
-
The relationship between remnant cholesterol and the risk of testosterone deficiency in US adults: a cross-sectional study based on the NHANES database.Front Endocrinol (Lausanne). 2024 Sep 24;15:1458193. doi: 10.3389/fendo.2024.1458193. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39387048 Free PMC article.
-
Remnant cholesterol in obesity phenotypes: results from NHANES.Lipids Health Dis. 2025 Apr 9;24(1):134. doi: 10.1186/s12944-025-02550-5. Lipids Health Dis. 2025. PMID: 40205563 Free PMC article.
-
Effects of Moderate Chronic Food Restriction on the Development of Postprandial Dyslipidemia with Ageing.Nutrients. 2019 Aug 10;11(8):1865. doi: 10.3390/nu11081865. Nutrients. 2019. PMID: 31405194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous